Q: Hi 5i:
Your last comment on Endo (ENL, ENDP.US) was Feb 29th and at that point you thought that it was unduly beaten down by the market given the company’s recent performance and outlook. That was when it was over $40 US. Now that it is under $30 US, what do you make of it? Is it worth continuing to hold or have fundamentals deteriorated to the point where alternative holdings in the same space look much better? How does it stack up on a comparison with CXR? Thanks!
Your last comment on Endo (ENL, ENDP.US) was Feb 29th and at that point you thought that it was unduly beaten down by the market given the company’s recent performance and outlook. That was when it was over $40 US. Now that it is under $30 US, what do you make of it? Is it worth continuing to hold or have fundamentals deteriorated to the point where alternative holdings in the same space look much better? How does it stack up on a comparison with CXR? Thanks!